Form 8-K - Current report:
SEC Accession No. 0001104659-24-076037
Filing Date
2024-06-28
Accepted
2024-06-28 08:20:26
Documents
13
Period of Report
2024-05-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2416299d1_8k.htm   iXBRL 8-K 30493
  Complete submission text file 0001104659-24-076037.txt   206177

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mnmd-20240528.xsd EX-101.SCH 3009
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnmd-20240528_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnmd-20240528_pre.xml EX-101.PRE 22355
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2416299d1_8k_htm.xml XML 3784
Mailing Address ONE WORLD TRADE CENTER SUITE 8500 NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER SUITE 8500 NEW YORK NY 10007 212-220-6633
Mind Medicine (MindMed) Inc. (Filer) CIK: 0001813814 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40360 | Film No.: 241081511
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)